Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A1 | P04798 | 9/20 | 0.51 |
| ▸ | CYP1B1 | Q16678 | 9/20 | 0.51 |
| ▸ | CYP1A2 | P05177 | 7/20 | 0.51 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | PRKDC | P78527 | 2/20 | 0.37 |
| ▸ | PIM1 | P11309 | 3/20 | 0.34 |
| ▸ | PIM2 | Q9P1W9 | 2/20 | 0.34 |
| ▸ | SERPINE1 | P05121 | 1/20 | 0.34 |
| ▸ | IDO1 | P14902 | 1/20 | 0.33 |
| ▸ | PIM3 | Q86V86 | 1/20 | 0.33 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23024877 | 0.88 | CYP1A1 (0.51) | CYP1A1CYP1B1CYP1A2KDM4EPIM1 | |
| SCHEMBL23314430 | 0.85 | CYP1A1 (0.43) | CYP1A1CYP1B1CYP1A2ALOX5KDM4E | |
| SCHEMBL24156104 | 0.85 | CYP1B1 (0.59) | CYP1A1CYP1B1CYP1A2ALOX5KDM4E | |
| SCHEMBL17167417 | 0.83 | ALOX5 (0.58) | CYP1A1CYP1B1CYP1A2ALOX5PRKDC | |
| SCHEMBL22424745 | 0.82 | ALOX5 (0.57) | ALOX5KDM4EPRKDCPIM1PIM2 | |
| SCHEMBL30150724 | 0.82 | ALOX5 (0.50) | CYP1A1CYP1B1CYP1A2ALOX5KDM4E | |
| SCHEMBL30203507 | 0.82 | ALOX5 (0.49) | ALOX5KDM4EPRKDCPIM1PIM2 | |
| SCHEMBL24969658 | 0.82 | ALOX5 (0.49) | ALOX5KDM4EPRKDCPIM1PIM2 | |
| SCHEMBL20349070 | 0.82 | CYP1A1 (0.59) | CYP1A1CYP1B1CYP1A2ALOX5CYP2A6 | |
| SCHEMBL29344301 | 0.82 | CYP1B1 (0.47) | CYP1A1CYP1B1CYP1A2ALOX5KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210242408-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING THE SAME, AND ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2021-08-05 | — | — | US | disclosed |
| US-10998502-B2 | Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2021-05-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10998502-B2 | Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof | OR51E2, ETV6, OR10J3 | CYP1A1 2720/4885CYP1B1 3998/4885CYP1A2 2769/4885 |
| US-20210242408-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING THE SAME, AND ELECTRONIC DEVICE THEREOF | OR10J3, OR51E2, ORAI2 | CYP1A1 3498/4885CYP1B1 4516/4885CYP1A2 3695/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.